Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - canine adeno virus type 2; canine distemper virus; canine parvo virus - parenteral liquid/solution/suspension - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | vaccine | canine adenovirus type 1 | canine adenovirus type 2 | equine rotavirus | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine distemper virus - living; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvo virus type 2 - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 qs dose; canine distemper virus - living vaccine-viral active 0.0 qs dose; canine parainfluenza virus vaccine-viral active 0.0 qs dose; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 qs dose; canine parvo virus type 2 vaccine-viral active 0.0 qs dose - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parvovirus | hepatitis :- infectious | parainfluenza virus type 2 (infections) | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infections caused by parainflu | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine adeno virus type 2; canine distemper virus; canine parainfluenza virus; canine parvo virus - parenteral liquid/solution/suspension - canine adeno virus type 2 vaccine-viral active 0.0 tci50/do; canine distemper virus vaccine-viral active 0.0 tci50/do; canine parainfluenza virus vaccine-viral active 0.0 tci50/do; canine parvo virus vaccine-viral active 0.0 tci50/do - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | respiratory disease | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine distemper virus - living; canine adenovirus type 2 - live (infectious hepatitis); canine parvovirus - live - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 p; canine adenovirus type 2 - live (infectious hepatitis) vaccine-viral active 0.0 p; canine parvovirus - live vaccine-viral active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | vaccine | canine adenovirus type 1 | canine adenovirus type 2 | equine rotavirus | infectious canine hepatitis | parvovirus

Philippines - English - FDA (Food And Drug Administration)

msd animal health (phils), inc.; distributor: msd animal health (phils), inc. - modified live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parainfluenza virus (cpi) , canine parvovirus (cpv) , inactivated leptospira interrogans ser. canicola , leptospira interrogans ser. icterohaemorrhagiae , coronavirus vaccine (vet.) - suspension for injection (im/sc) - formulation: each dose of dappvla vaccine contains: modified live virus canine distemper virus (cdv) (distemperoid strain) >10^3.7 tcid 50/dose modified live virus canine adenovirus type 2 (cav-2) (ditchfield strain) >10^4.8 tcid 50/dose modified live virus canine parainfluenza (cpi) (cpi-pr strain)- >10^4.3 tcid 50/dose modified live virus canine parvovirus (cpv) (sah-cpv-2b strain) >10^5.1 tcid 50/dose bacterin leptospira canicola (lc-ny strain)>80 hamster pd80 bacterin leptospira icterohaemorrhagiae (li-11403 j strain)>80 hamster pd80 each dose of canine 1-cv vaccine contains: killed virus feline enteric coronavirus (fecv) (wsu 79-1683(3) strain) >1 rp/dose tcid-test culture infectious dose faid- flouroscent antibody infect due pd-protective dose rp-relative potency

Philippines - English - FDA (Food And Drug Administration)

unahco, inc.; distributor: unahco, inc. - live canine distemper virus (cdv) , canine adenovirus type 2 (cav-2) , canine parvovirus (cpv) , inactivated canine adenovirus type 1 (cav-1) , leptospira interrogans ser. canicola , l. interrogans ser. ictero haemorrhagiae vaccine (vet.) - freeze-dried pellet for injection (im/sc) - formulation: each 1 ml (dose) contains: canine distemper virus ........>10^3 tcid50 canine adenovirus type 2 .............................. > 10^3 tcid50 canine parvovirus .................................. >128 ha canine adenovirus type 1 ................ > 81 sn50/ 0.05 ml leptospira interrogans ser. canicola leptospira interrogans ser. icterohaemorrhagiae tcid - tissue culture infective dose ha - hemagglutination assay sn-serum neutralization

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2; thiomersal - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus - living vaccine-viral active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p; canine parvo virus type 2 vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine distemper virus; canine parainfluenza virus; canine adenovirus type 2 live (cav ii); canine parvovirus - live; gentamicin - misc. vaccines or anti sera - canine distemper virus vaccine-viral active 0.0 u; canine parainfluenza virus vaccine-viral active 0.0 u; canine adenovirus type 2 live (cav ii) vaccine-viral active 0.0 u; canine parvovirus - live vaccine-viral active 0.0 u; gentamicin antibiotic other 30.0 ug/ml - immunotherapy

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Philippines - English - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (cpv) (c-780916 strain)->10^7 tcid50 canine distemper (cd) virus (lederle strain)->10^5 tcid50 tcid-tissue culture inleutive dose